
Quarterly report 2025-Q3
added 10-31-2025
Chemed Corporation EBITDA 2011-2026 | CHE
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA Chemed Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 430 M | 401 M | 403 M | 402 M | 446 M | 312 M | 284 M | 240 M | 213 M | 218 M | 201 M | 192 M | 187 M | 183 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 446 M | 183 M | 294 M |
Quarterly EBITDA Chemed Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88.4 M | 81.8 M | 111 M | 105 M | 101 M | 88.1 M | 99.7 M | 82.1 M | 87.6 M | - | 93 M | 105 M | 104 M | - | 138 M | 85.3 M | 94.7 M | - | 117 M | 121 M | 93.2 M | - | 96 M | 86 M | 59.7 M | - | 90.5 M | 77.2 M | 65.7 M | - | 80.7 M | -21.1 M | 50.4 M | - | 68.8 M | 55.6 M | 52.9 M | - | 74.7 M | 61 M | 48.7 M | - | 64.5 M | 57.7 M | 43.8 M | - | 36.2 M | 32.8 M | 45.6 M | - | 42.5 M | 45.9 M | 41.2 M | - | 47.6 M | 42.2 M | 36.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 138 M | -21.1 M | 72.9 M |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Care facilities industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Мать и Дитя
MDMG
|
8.13 B | - | - | - | ||
|
Addus HomeCare Corporation
ADUS
|
155 M | $ 103.36 | -1.81 % | $ 1.87 B | ||
|
Concord Medical Services Holdings Limited
CCM
|
-394 M | $ 3.43 | -6.03 % | $ 450 M | ||
|
COMPASS Pathways plc
CMPS
|
-178 M | $ 6.95 | -1.0 % | $ 469 M | ||
|
Amedisys
AMED
|
121 M | - | 0.01 % | $ 3.3 B | ||
|
Apollo Medical Holdings
AMEH
|
102 M | - | -2.11 % | $ 1.84 B | ||
|
Hanger
HNGR
|
105 M | - | - | $ 732 M | ||
|
The Ensign Group
ENSG
|
530 M | $ 213.13 | -1.25 % | $ 12.2 B | ||
|
Avalon GloboCare Corp.
AVCO
|
-4.75 M | - | 26.45 % | $ 70.6 M | ||
|
Genesis Healthcare, Inc.
GEN
|
-162 M | - | - | $ 68.1 M | ||
|
The Joint Corp.
JYNT
|
7.47 M | $ 8.63 | 0.82 % | $ 125 M | ||
|
Fresenius Medical Care AG & Co. KGaA
FMS
|
3.48 B | $ 23.37 | -0.43 % | $ 7.05 B | ||
|
Aesthetic Medical International Holdings Group Limited
AIH
|
53.3 M | - | 10.96 % | $ 46.2 M | ||
|
Capital Senior Living Corporation
CSU
|
-235 M | - | -2.09 % | $ 216 M | ||
|
LHC Group
LHCG
|
132 M | - | - | $ 5.27 B | ||
|
Five Star Senior Living Inc.
FVE
|
26.9 M | - | -0.32 % | $ 98.4 M | ||
|
New Frontier Health Corporation
NFH
|
354 M | - | 3.54 % | $ 1.5 B | ||
|
Brookdale Senior Living
BKD
|
384 M | $ 14.99 | -0.89 % | $ 3.53 B | ||
|
Encompass Health Corporation
EHC
|
328 M | $ 108.01 | -0.05 % | $ 10.9 B | ||
|
Acadia Healthcare Company
ACHC
|
150 M | $ 22.99 | -1.92 % | $ 2.11 B | ||
|
HCA Healthcare
HCA
|
3.52 B | $ 541.8 | 1.67 % | $ 128 B | ||
|
Oak Street Health
OSH
|
-97 M | - | 0.03 % | $ 9.53 B | ||
|
AMN Healthcare Services
AMN
|
499 M | $ 20.99 | 2.89 % | $ 822 M | ||
|
American Shared Hospital Services
AMS
|
3.37 M | $ 2.08 | -0.95 % | $ 13.5 M | ||
|
Healthcare Services Group
HCSG
|
16.8 M | $ 21.3 | -4.14 % | $ 1.54 B | ||
|
IMAC Holdings
IMAC
|
-5.48 M | - | -1.77 % | $ 25.4 M | ||
|
Community Health Systems
CYH
|
1.91 B | $ 3.45 | 1.77 % | $ 461 M | ||
|
DaVita
DVA
|
2.75 B | $ 152.27 | -1.11 % | $ 11.3 B | ||
|
Elanco Animal Health Incorporated
ELAN
|
680 M | $ 24.88 | -4.64 % | $ 12.4 B | ||
|
Phibro Animal Health Corporation
PAHC
|
156 M | $ 52.27 | -4.16 % | $ 2.12 B | ||
|
Select Medical Holdings Corporation
SEM
|
476 M | $ 16.26 | 8.4 % | $ 1.99 B | ||
|
Sanara MedTech
SMTI
|
-540 K | $ 20.84 | 1.76 % | $ 173 M | ||
|
The Pennant Group
PNTG
|
60.4 M | $ 33.02 | -2.37 % | $ 1.14 B | ||
|
Tenet Healthcare Corporation
THC
|
4.37 B | $ 242.88 | 3.3 % | $ 21.9 B | ||
|
MEDNAX
MD
|
231 M | $ 19.74 | 0.87 % | $ 1.66 B | ||
|
ModivCare
MODV
|
16.7 M | - | -25.23 % | $ 6.12 M | ||
|
U.S. Physical Therapy
USPH
|
109 M | $ 83.25 | 0.26 % | $ 1.26 B | ||
|
National HealthCare Corporation
NHC
|
173 M | $ 170.51 | -0.37 % | $ 2.64 B | ||
|
Novo Integrated Sciences
NVOS
|
-7.81 M | - | -13.87 % | $ 1.52 M | ||
|
Option Care Health
OPCH
|
405 M | $ 31.2 | -1.27 % | $ 5.06 B | ||
|
Ontrak
OTRK
|
-17.2 M | - | -11.98 % | $ 1.53 M | ||
|
Regional Health Properties
RHE
|
2.22 M | - | - | $ 5.2 M | ||
|
Surgery Partners
SGRY
|
566 M | $ 13.92 | -12.34 % | $ 1.77 B | ||
|
SunLink Health Systems
SSY
|
-1.04 M | - | 17.98 % | $ 7.81 M | ||
|
Universal Health Services
UHS
|
2.61 B | $ 204.85 | -0.76 % | $ 13 B | ||
|
Tivity Health
TVTY
|
154 M | - | 0.09 % | $ 1.6 B |